Investor & Partner Preview · April 2026
Decoding Skin
Glacies Biome helps longevity, wellness, aesthetic, and skincare clinics hyper-personalize care, increase loyalty, and turn every patient journey into measurable outcome data.
Strong commercial traction
Paying customers in the EU and Switzerland with +$1.38M ARR contracts signed; US expansion underway.
B2B platform for personalized skin health
Multi-modal AI links long-read 16S skin microbiome data, facial visual analysis, lifestyle, treatment history, and environment to generate personalized routines, clinic protocols, and longitudinal skin intelligence.
Supported by
What we're building
A molecular-level platform for
aesthetic clinics
built on microbiome science, AI and a proprietary collagen biomarker technology
We save clinicians hours and generate treatment plans and longitudinal outcome data for driving customer royalty.
Long-read 16S microbiome data helps Glacies understand how skin is likely to respond across treatments, products, and recovery windows.
For clinics and partners, the same workflow becomes an operating and intelligence layer: patient retention, outcome tracking, product performance, and portfolio decisions in one view.